BCYC
Bicycle Therapeutics·NASDAQ
--
--(--)
--
--(--)
BCYC fundamentals
During Q4 2025, Bicycle Therapeutics (BCYC) reported revenue of 47.95M, a YoY change of 1193.28%. Net income was -20.15M, a YoY change of 61.13%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q4,2017 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Oct 1, 2017 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Dec 31, 2017 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 655.00K -- | 1.66M -- | 1.61M -- | 1.06M +61.37% | 6.38M -- | 1.52M -8.37% | 614.00K -61.86% | 5.28M +399.62% | 1.13M -82.32% | 1.57M +3.22% | 3.84M +525.73% | 3.85M -27.14% | 1.81M +60.14% | 1.78M +13.62% | 4.33M +12.78% | 3.77M -2.00% | 3.86M +113.50% | 4.38M +145.27% | 3.04M -29.84% | 3.19M -15.54% | 4.90M +26.84% | 11.40M +160.32% | 5.35M +76.05% | 5.33M +67.38% | 19.53M +298.90% | 9.36M -17.86% | 2.68M -50.00% | 3.71M -30.44% | 9.98M -48.91% | 2.92M -68.81% | 11.73M +338.49% | 47.95M +1193.28% | 72.59M -- |
Sales and Services Revenue | 655.00K -- | 1.66M -- | 1.61M -- | 1.06M +61.37% | 6.38M -- | 1.52M -8.37% | 614.00K -61.86% | 5.28M +399.62% | 1.13M -82.32% | 1.57M +3.22% | 3.84M +525.73% | 3.85M -27.14% | 1.81M +60.14% | 1.78M +13.62% | 4.33M +12.78% | 3.77M -2.00% | 3.86M +113.50% | 4.38M +145.27% | 3.04M -29.84% | 3.19M -15.54% | 4.90M +26.84% | 11.40M +160.32% | 5.35M +76.05% | 5.33M +67.38% | 19.53M +298.90% | 9.36M -17.86% | 2.68M -50.00% | 3.71M -30.44% | 9.98M -48.91% | 2.92M -68.81% | 11.73M +338.49% | 47.95M +1193.28% | 72.59M -- |
Cost of Revenue | 0 -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | 655.00K -- | 1.66M -- | 1.61M -- | 1.06M +61.37% | 6.38M -- | 1.52M -8.37% | 614.00K -61.86% | 5.28M +399.62% | 1.13M -82.32% | 1.57M +3.22% | 3.84M +525.73% | -6.54M -223.88% | 1.81M +60.14% | 1.78M +13.62% | 4.33M +12.78% | -7.93M -21.16% | 3.86M +113.50% | 4.38M +145.27% | 3.04M -29.84% | -11.28M -42.29% | 4.90M +26.84% | 11.40M +160.32% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 6.67M -- | 6.62M -- | 7.97M -- | 8.60M +28.82% | 9.68M -- | 9.51M +43.68% | 10.87M +36.40% | 10.04M +16.82% | 12.77M +31.97% | 14.15M +48.83% | 14.52M +33.59% | 20.91M +108.14% | 17.83M +39.62% | 19.06M +34.68% | 18.63M +28.31% | 21.80M +4.24% | 31.24M +75.21% | 31.68M +66.18% | 32.80M +76.08% | 35.40M +62.40% | 46.70M +49.47% | 54.51M +72.07% | 56.15M +71.19% | 59.57M +68.28% | 51.25M +9.74% | 56.01M +2.75% | 66.52M +18.47% | 71.37M +19.82% | 80.18M +56.46% | 89.52M +59.84% | 77.28M +16.18% | 72.66M +1.81% | 319.65M -- |
Selling, General and Administrative Expenses | 2.57M -- | 1.70M -- | 2.33M -- | 2.11M -18.05% | 3.40M -- | 2.97M +74.68% | 4.79M +105.98% | 3.40M +61.25% | 5.00M +46.91% | 6.20M +108.41% | 7.15M +49.38% | 10.85M +219.49% | 8.14M +62.85% | 7.34M +18.46% | 8.11M +13.42% | 8.84M -18.53% | 16.96M +108.37% | 11.82M +61.09% | 10.05M +23.82% | 10.68M +20.79% | 14.49M -14.57% | 14.79M +25.07% | 16.28M +62.05% | 14.87M +39.26% | 16.38M +13.07% | 15.95M +7.85% | 18.26M +12.14% | 21.59M +45.22% | 21.12M +28.94% | 18.49M +15.95% | 18.86M +3.30% | 20.89M -3.24% | 79.37M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 29.20M -- | -- -- | -- -- | -- -- | 32.44M +11.07% | -- -- | -- -- | -- -- | 49.51M +52.63% | -- -- | -- -- | 16.28M -- | 14.87M -69.97% | 16.38M -- | 15.95M -- | 18.26M +12.14% | 21.59M +45.22% | 21.12M +28.94% | 18.49M +15.95% | 18.86M +3.30% | 20.89M -3.24% | 79.37M -- |
Research and Development Expenses | 4.11M -- | 4.92M -- | 5.64M -- | 6.49M +58.17% | 6.28M -- | 6.54M +32.95% | 6.08M +7.73% | 6.65M +2.40% | 7.77M +23.87% | 7.96M +21.74% | 7.36M +21.14% | 10.06M +51.27% | 9.69M +24.68% | 11.72M +47.30% | 10.51M +42.78% | 12.96M +28.81% | 14.28M +47.36% | 19.85M +69.37% | 22.75M +116.42% | 24.72M +90.79% | 32.21M +125.50% | 39.72M +100.06% | 39.87M +75.23% | 44.70M +80.82% | 34.86M +8.24% | 40.06M +0.85% | 48.27M +21.06% | 49.78M +11.37% | 59.06M +69.40% | 71.03M +77.31% | 58.43M +21.05% | 51.77M +4.00% | 240.28M -- |
Operating Income | -6.02M -- | -4.96M -- | -6.36M -- | -7.54M -25.28% | -3.29M -- | -7.99M -61.11% | -10.25M -61.29% | -4.76M +36.83% | -11.64M -253.46% | -12.58M -57.52% | -10.68M -4.12% | -17.06M -258.10% | -16.02M -37.63% | -17.28M -37.30% | -14.29M -33.90% | -18.02M -5.65% | -27.38M -70.89% | -27.30M -58.01% | -29.76M -108.19% | -32.21M -78.71% | -41.80M -52.66% | -43.11M -57.92% | -50.80M -70.69% | -54.23M -68.37% | -31.72M +24.13% | -46.65M -8.20% | -63.85M -25.69% | -67.66M -24.76% | -70.20M -121.35% | -86.60M -85.65% | -65.55M -2.67% | -24.71M +63.48% | -247.06M -- |
Non-Operating Income (Loss) | 204.00K -- | -21.00K -- | -1.33M -- | 901.00K +341.67% | -3.13M -- | -2.09M -9871.43% | 440.00K +132.96% | 220.00K -75.58% | 212.00K +106.78% | 371.00K +117.72% | 72.00K -83.64% | -429.00K -295.00% | -507.00K -339.15% | -796.00K -314.56% | -799.00K -1209.72% | -761.00K -77.39% | -600.00K -18.34% | 25.00K +103.14% | 1.17M +246.93% | 1.81M +338.24% | 2.12M +453.50% | -9.00K -136.00% | 3.17M +170.10% | 5.46M +200.94% | 4.80M +126.45% | 6.95M +77322.22% | 9.60M +202.62% | 14.73M +169.92% | 8.36M +74.12% | 7.42M +6.75% | 6.66M -30.64% | 5.82M -60.49% | 28.26M -- |
Other Non-Operating Income (Loss) | 204.00K -- | -21.00K -- | -1.33M -- | 732.00K +258.82% | -3.13M -- | -2.09M -9871.43% | 440.00K +132.96% | -594.00K -181.15% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -954.00K -- | 4.48M -- | -- -- | -- -- | 0 +100.00% | 0 -100.00% | -- -- |
Net Interest Expense | -- -- | -- -- | -- -- | -169.00K -- | -- -- | -- -- | -- -- | -814.00K -381.66% | -212.00K -- | -371.00K -- | -72.00K -- | 429.00K +152.70% | 507.00K +339.15% | 796.00K +314.56% | 799.00K +1209.72% | 761.00K +77.39% | 600.00K +18.34% | -25.00K -103.14% | -1.17M -246.93% | -1.81M -338.24% | -2.12M -453.50% | 9.00K +136.00% | -3.17M -170.10% | -5.46M -200.94% | -4.80M -126.45% | -6.95M -77322.22% | -10.55M -232.70% | -10.25M -87.88% | -8.36M -74.12% | -7.42M -6.75% | -6.66M +36.91% | -5.82M +43.23% | -28.26M -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 457.00K -- | 522.00K -- | 819.00K -- | 823.00K -- | 820.00K +79.43% | 818.00K +56.70% | 883.00K +7.81% | 817.00K -0.73% | 826.00K +0.73% | 808.00K -1.22% | 821.00K -7.02% | 814.00K -0.37% | 820.00K -0.73% | 821.00K +1.61% | 824.00K +0.37% | 33.00K -95.95% | 52.00K -93.66% | 51.00K -93.79% | 54.00K -93.45% | 44.00K +33.33% | 57.00K +9.62% | 206.00K -- |
Interest Income | -- -- | -- -- | -- -- | 169.00K -- | -- -- | -- -- | -- -- | 814.00K +381.66% | 212.00K -- | 371.00K -- | 72.00K -- | 28.00K -96.56% | 15.00K -92.92% | 23.00K -93.80% | 24.00K -66.67% | 59.00K +110.71% | 218.00K +1353.33% | 908.00K +3847.83% | 1.99M +8195.83% | 2.64M +4372.88% | 2.93M +1243.58% | 812.00K -10.57% | 3.98M +100.15% | 6.28M +137.82% | 5.62M +92.01% | 7.77M +857.39% | 10.58M +165.57% | 10.30M +64.17% | 8.41M +49.61% | 7.47M -3.87% | 6.70M -36.69% | 5.88M -42.97% | 28.46M -- |
Pretax Income From Continuing Operations | -5.82M -- | -4.98M -- | -7.69M -- | -6.64M -14.19% | -6.42M -- | -10.08M -102.49% | -9.81M -27.57% | -4.54M +31.58% | -11.43M -77.97% | -12.21M -21.13% | -10.60M -8.05% | -17.49M -284.88% | -16.53M -44.62% | -18.07M -47.99% | -15.09M -42.35% | -18.79M -7.41% | -27.98M -69.28% | -27.27M -50.92% | -28.59M -89.39% | -30.40M -61.82% | -39.68M -41.81% | -43.12M -58.09% | -47.63M -66.61% | -48.78M -60.47% | -26.91M +32.18% | -39.70M +7.94% | -54.25M -13.91% | -52.94M -8.52% | -61.84M -129.78% | -79.18M -99.47% | -58.90M -8.56% | -18.89M +64.32% | -218.81M -- |
Income Tax Expense | 9.00K -- | -- -- | 0 -- | 0 -100.00% | 80.00K -- | 135.00K -- | -331.00K -- | -138.00K -- | -107.00K -233.75% | -97.00K -171.85% | -465.00K -40.48% | -56.00K +59.42% | -340.00K -217.76% | -160.00K -64.95% | -415.00K +10.75% | -748.00K -1235.71% | -419.00K -23.24% | -447.00K -179.38% | -238.00K +42.65% | -420.00K +43.85% | -618.00K -47.49% | -517.00K -15.66% | 2.27M +1054.62% | 320.00K +176.19% | -350.00K +43.37% | 115.00K +122.24% | -3.45M -251.76% | -1.08M -438.12% | -1.09M -210.57% | -231.00K -300.87% | 205.00K +105.95% | 1.26M +216.91% | 152.00K -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -51.00K -- | -- -- | -- -- | -- -- | 5.00K +109.80% | -- -- | -- -- | -- -- | 3.45M +68940.00% | -- -- | -- -- | -- -- | -1.85M -153.56% | -- -- | -- -- | -- -- | 461.00K +124.93% | -- -- | -- -- | -- -- | 1.00M +117.35% | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -673.00K -- | -- -- | -- -- | -- -- | -1.67M -147.85% | -- -- | -- -- | -- -- | -4.98M -198.32% | -- -- | -- -- | -- -- | 3.31M +166.44% | -- -- | -- -- | -- -- | -5.23M -258.08% | -- -- | -- -- | -- -- | -850.00K +83.74% | -- -- |
Net Income | -5.83M -- | -4.98M -- | -7.69M -- | -6.64M -14.01% | -6.50M -- | -10.22M -105.20% | -9.48M -23.27% | -4.41M +33.65% | -11.32M -74.14% | -12.12M -18.58% | -10.14M -6.92% | -17.43M -295.67% | -16.19M -42.98% | -17.91M -47.86% | -14.68M -44.78% | -18.04M -3.46% | -27.56M -70.24% | -26.83M -49.77% | -28.35M -93.13% | -29.98M -66.20% | -39.06M -41.72% | -42.60M -58.80% | -49.90M -76.03% | -49.10M -63.78% | -26.56M +32.00% | -39.81M +6.55% | -50.80M -1.81% | -51.85M -5.61% | -60.75M -128.72% | -78.95M -98.31% | -59.10M -16.33% | -20.15M +61.13% | -218.96M -- |
Net Income Attributable to Owners of the Company | -5.83M -- | -4.98M -- | -7.69M -- | -6.64M -14.01% | -6.50M -- | -10.22M -105.20% | -9.48M -23.27% | -4.41M +33.65% | -11.32M -74.14% | -12.12M -18.58% | -10.14M -6.92% | -17.43M -295.67% | -16.19M -42.98% | -17.91M -47.86% | -14.68M -44.78% | -18.04M -3.46% | -27.56M -70.24% | -26.83M -49.77% | -28.35M -93.13% | -29.98M -66.20% | -39.06M -41.72% | -42.60M -58.80% | -49.90M -76.03% | -49.10M -63.78% | -26.56M +32.00% | -39.81M +6.55% | -50.80M -1.81% | -51.85M -5.61% | -60.75M -128.72% | -78.95M -98.31% | -59.10M -16.33% | -20.15M +61.13% | -218.96M -- |
Net Income Attributable to Common Stockholders | -5.83M -- | -4.98M -- | -7.69M -- | -6.64M -14.01% | -6.50M -- | -10.22M -105.20% | -9.48M -23.27% | -4.41M +33.65% | -11.32M -74.14% | -12.12M -18.58% | -10.14M -6.92% | -17.43M -295.67% | -16.19M -42.98% | -17.91M -47.86% | -14.68M -44.78% | -18.04M -3.46% | -27.56M -70.24% | -26.83M -49.77% | -28.35M -93.13% | -29.98M -66.20% | -39.06M -41.72% | -42.60M -58.80% | -49.90M -76.03% | -49.10M -63.78% | -26.56M +32.00% | -39.81M +6.55% | -50.80M -1.81% | -51.85M -5.61% | -60.75M -128.72% | -78.95M -98.31% | -59.10M -16.33% | -20.15M +61.13% | -218.96M -- |
Other Comprehensive Income | 647.00K -- | -2.66M -- | -537.00K -- | -422.00K -165.22% | 1.08M -- | -1.51M +43.09% | -424.00K +21.04% | 1.07M +354.03% | -2.18M -302.22% | -1.00K +99.93% | 743.00K +275.24% | -216.00K -120.15% | -58.00K +97.34% | -255.00K -25400.00% | 313.00K -57.87% | -195.00K +9.72% | 920.00K +1686.21% | 2.09M +921.18% | 902.00K +188.18% | -141.00K +27.69% | -316.00K -134.35% | -948.00K -145.27% | 3.76M +317.07% | -4.19M -2870.92% | 526.00K +266.46% | -314.00K +66.88% | -2.09M -155.64% | 3.30M +178.87% | -1.58M -400.38% | -1.90M -505.73% | -108.00K +94.84% | -34.00K -101.03% | -3.62M -- |
Total Comprehensive Income | -5.18M -- | -7.64M -- | -8.23M -- | -7.06M -36.40% | -5.42M -- | -11.73M -53.60% | -9.91M -20.38% | -3.33M +52.80% | -13.51M -149.09% | -12.12M -3.30% | -9.39M +5.16% | -17.65M -429.36% | -16.25M -20.29% | -18.17M -49.95% | -14.37M -52.90% | -18.23M -3.30% | -26.64M -63.97% | -24.73M -36.14% | -27.45M -91.05% | -30.12M -65.20% | -39.38M -47.80% | -43.55M -76.08% | -46.14M -68.10% | -53.29M -76.92% | -26.04M +33.88% | -40.13M +7.86% | -52.90M -14.65% | -48.55M +8.89% | -62.33M -139.41% | -80.85M -101.50% | -59.21M -11.93% | -20.19M +58.42% | -222.58M -- |
Total Comprehensive Income Attributable to Owners of the Company | -5.18M -- | -7.64M -- | -8.23M -- | -7.06M -36.40% | -5.42M -- | -11.73M -53.60% | -9.91M -20.38% | -3.33M +52.80% | -13.51M -149.09% | -12.12M -3.30% | -9.39M +5.16% | -17.65M -429.36% | -16.25M -20.29% | -18.17M -49.95% | -14.37M -52.90% | -18.23M -3.30% | -26.64M -63.97% | -24.73M -36.14% | -27.45M -91.05% | -30.12M -65.20% | -39.38M -47.80% | -43.55M -76.08% | -46.14M -68.10% | -53.29M -76.92% | -26.04M +33.88% | -40.13M +7.86% | -52.90M -14.65% | -48.55M +8.89% | -62.33M -139.41% | -80.85M -101.50% | -59.21M -11.93% | -20.19M +58.42% | -222.58M -- |
Basic EPS | -- -- | -11.85 -- | -17.73 -- | -- -- | -7.8 -- | -1.4 +88.19% | -0.53 +97.01% | -0.24 -- | -0.63 +91.92% | -0.67 +52.14% | -0.52 +1.89% | -0.83 -245.83% | -0.73 -15.87% | -0.74 -10.45% | -0.59 -13.46% | -0.61 +26.51% | -0.93 -27.40% | -0.9 -21.62% | -0.96 -62.71% | -1 -63.93% | -1.3 -39.78% | -1.41 -56.67% | -1.26 -31.25% | -1.16 -16.00% | -0.62 +52.31% | -0.77 +45.39% | -0.74 +41.27% | -0.75 +35.34% | -0.88 -41.94% | -1.14 -48.05% | -0.85 -14.86% | -0.29 +61.33% | -3.16 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.26 -- | -- -- | -0.62 -- | -0.77 -- | -0.74 +41.27% | -- -- | -0.88 -41.94% | -1.14 -48.05% | -0.85 -14.86% | -- -- | -- -- |
Diluted EPS | -- -- | -11.85 -- | -17.73 -- | -- -- | -7.8 -- | -1.4 +88.19% | -0.53 +97.01% | -- -- | -0.63 +91.92% | -0.67 +52.14% | -0.52 +1.89% | -- -- | -0.73 -15.87% | -0.74 -10.45% | -0.59 -13.46% | -- -- | -0.93 -27.40% | -0.9 -21.62% | -0.96 -62.71% | -- -- | -1.3 -39.78% | -1.41 -56.67% | -1.26 -31.25% | -- -- | -0.62 +52.31% | -0.77 +45.39% | -0.74 +41.27% | -- -- | -0.88 -41.94% | -1.14 -48.05% | -0.85 -14.86% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.26 -- | -- -- | -0.62 -- | -0.77 -- | -0.74 +41.27% | -- -- | -0.88 -41.94% | -1.14 -48.05% | -0.85 -14.86% | -- -- | -- -- |
You can ask Aime
What were the key takeaways from Bicycle Therapeutics’s earnings call?What were the key takeaways from Bicycle Therapeutics's earnings call?What is Bicycle Therapeutics's gross profit margin?What is Bicycle Therapeutics's latest dividend and current dividend yield?What does Bicycle Therapeutics do and what are its main business segments?What factors drove the changes in Bicycle Therapeutics's revenue and profit?What guidance did Bicycle Therapeutics's management provide for the next earnings period?Did Bicycle Therapeutics beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
